SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-030782
Filing Date
2019-08-08
Accepted
2019-08-08 16:11:16
Documents
3
Period of Report
2019-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prnb-8k_20190808.htm 8-K 35885
2 EX-99.1 prnb-ex991_40.htm EX-99.1 89552
3 GRAPHIC gakwttobvk1p000001.jpg GRAPHIC 4729
  Complete submission text file 0001564590-19-030782.txt   133247
Mailing Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080 (650) 416-7700
Principia Biopharma Inc. (Filer) CIK: 0001510487 (see all company filings)

IRS No.: 263487603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38653 | Film No.: 191009609
SIC: 2834 Pharmaceutical Preparations